Renaissance for Italian AIDS Program

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Renaissance for Italian AIDS Program

Science (12/19/97) Vol. 278, No. 5346, P. 2061

Abstract: The Italian government has overhauled its AIDS research program, now making grant applications anonymous in response to charges that the National Program for AIDS Research played favorites. The revised program divides funding into pathogenesis, with $6 million, therapy with $4 million, opportunistic infections with $2.5 million, and epidemiology with $1.5 million. Furthermore, where basic research used to receive about half the overall funding, the new program allots it only about 10 percent. While many researchers are relieved at the program's new life, some note that the review procedure --under which progress reports written by groups applying for continuing funding are withheld from reviewers--seems impractical. Alberto Mantovani, of the Mario Negri Institute in Milan, says the new policy is "nonsense," adding that the report is "a crucial element in the refereeing process."

971229
AD972359

Copyright © 1997 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.